Obese asthma phenotypes display distinct plasma biomarker profiles.

"CONFLICT OF INTEREST STATEMENT EM reports lecture, consulting or advisory boards fees from AstraZeneca, Chiesi, Novartis and Sanofi outside the submitted work. SK reports lecture or advisory boards fees from Novartis and AstraZeneca outside the submitted work. MvH has received lecture fee from Thermo Fisher Scientific outside the submitted work. The other authors declare no conflicts of interest."

"We thank the subjects and parents participating in the BAMSE cohort and all staff involved in the study through the years. This work was supported by grants from the Swedish Research Council (2016–03086; 2018–02524; 2019‐01060; 2020–02170), the Swedish Research Council for Health, Working Life and Welfare (2017‐00526), Formas (2016‐01646), the Swedish Heart‐Lung Foundation, the European Research Council (TRIBAL, grant agreement 757919), Cancer‐ and Allergy Foundation, the Swedish Asthma and Allergy research foundation and Region Stockholm (ALF project, SK clinical postdoctoral appointment, and for cohort and database maintenance). NHP was supported by a Medium‐Term Research Fellowship by the European Academy of Allergy and Clinical Immunology (EAACI) and a Long‐Term Research Fellowship by the European Respiratory Society (ERS) (LTRF202101‐00861). Thermo Fisher Scientific kindly provided reagents for the allergen‐specific IgE analyses."